Picard Medical, Inc. (NYSE MKT:PMI) — Market Cap & Net Worth
Market Cap & Net Worth: Picard Medical, Inc. (PMI)
Picard Medical, Inc. (NYSE MKT:PMI) has a market capitalization of $12.98 Million ($12.98 Million) as of May 22, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #26360 globally and #5370 in its home market, demonstrating a -10.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Picard Medical, Inc.'s stock price $0.14 by its total outstanding shares 92042143 (92.04 Million). Analyse PMI cash generation efficiency to see how efficiently the company converts income to cash.
Picard Medical, Inc. Market Cap History: 2025 to 2026
Picard Medical, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $161.07 Million to $12.98 Million (0.00% CAGR).
Picard Medical, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Picard Medical, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
32.61x
Picard Medical, Inc.'s market cap is 32.61 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $161.07 Million | $4.94 Million | -$27.00 Million | 32.61x | N/A |
Competitor Companies of PMI by Market Capitalization
Companies near Picard Medical, Inc. in the global market cap rankings as of May 22, 2026.
Key companies related to Picard Medical, Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $152.62 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #198 globally with a market cap of $119.97 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #257 globally with a market cap of $97.77 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $152.62 Billion | $87.77 |
| #198 | Stryker Corporation | NYSE:SYK | $119.97 Billion | $313.50 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #257 | Medtronic PLC | NYSE:MDT | $97.77 Billion | $78.15 |
Picard Medical, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Picard Medical, Inc.'s market cap moved from $161.07 Million to $ 12.98 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $12.98 Million | -91.94% |
| 2025 | $161.07 Million | -- |
End of Day Market Cap According to Different Sources
On May 22nd, 2026 the market cap of Picard Medical, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.98 Million USD |
| MoneyControl | $12.98 Million USD |
| MarketWatch | $12.98 Million USD |
| marketcap.company | $12.98 Million USD |
| Reuters | $12.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more